http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-42644-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_600db5b93a54999d3db277d10725d525 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08 |
| filingDate | 1976-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1980-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-42644-B1 |
| titleOfInvention | (indolin-1-yl)-guanidines |
| abstract | Compounds of the formula I in which the individual substituents have the meanings stated in the claim, are prepared. The process is based on replacement of an -SR9 group in which R9 denotes lower alkyl by the -NR2R3 group. The resulting products of the formula I and their acid addition salts have antihypertensive properties and properties increasing venous tone. |
| priorityDate | 1975-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.